AATec Medical treats inflammatory illnesses, viral infections, and uncommon diseases with recombinant alpha-1 antitrypsin (AAT).
AATec Medical has raised $2.7M in total funding. The most recent round was Seed. The last funding was announced in July 2023.
AATec Medical is headquartered in Munich, Germany.
AATec Medical treats inflammatory illnesses, viral infections, and uncommon diseases with recombinant alpha-1 antitrypsin (AAT).
AATec Medical is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AATec Medical — Funding & Investors." VCBacked, July 17, 2023, https://www.vcbacked.co/company/aatec-medical. Accessed September 5, 2026.
VCBacked. (2023). AATec Medical — Funding & Investors. Retrieved September 5, 2026, from https://www.vcbacked.co/company/aatec-medical
{{cite web |title=AATec Medical — Funding & Investors |url=https://www.vcbacked.co/company/aatec-medical |website=VCBacked |access-date=September 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated